Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects
Year: 2012
Type: review
Source: The Pharmacogenomics Journal
DOI: 10.1038/tpj.2012.45
Authors: S C Sim, M Kacevska, M Ingelman-Sundberg
Institution: Karolinska Institutet
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Keywords: pharmacogenomics, drug-metabolizing enzymes, drug metabolism polymorphisms, CYP2C19, clopidogrel, CYP2C9, VKORC1, anticoagulation, CYP2D6, tamoxifen, breast cancer recurrence, antidepressants, suicide risk, CYP3A5, tacrolimus dosing, CYP1A2, blood pressure, coffee consumption, CYP2A6, cigarette smoking, lung cancer, thiopurine S-methyltransferase, UGT1A1, irinotecan, 6-mercaptopurine, genome-wide association study, drug response
Open Access status: closed
OpenAlex ID: W1985338499
